Thousands of bottles of a prescription medicine for treating high blood pressure and congestive heart failure have been recalled over the detection of trace amounts of a possible carcinogen. About ...
Another pharmaceutical company has recalled its Losartan tablets because of the detection of a trace amount of a potential cancer-causing contaminant. Camber Pharmaceuticals, Inc. has recalled 87 lots ...
More blood pressure drugs are being recalled after being found to contain trace amounts of a potentially cancer-causing ingredient, one of a slew of recalls of medications to treat hypertension. Since ...
Thousands of bottles of blood-pressure medicine are being recalled after the Food and Drug Administration said trace amounts of potential carcinogens were found to be in the medicine. Camber ...
Chika E. Okereke, MD; Franz H. Messerli, MD, Department of Internal Medicine, Section on Hypertensive Diseases, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, LA A total of 57% of ...
Berlin, Germany - The angiotensin II antagonist losartan (Cozaar®, Merck) failed to show benefits over the ACE-inhibitor captopril in the Optimal Trial in Myocardial Infarction with the Angiotensin II ...
Please provide your email address to receive an email when new articles are posted on . Losartan failed to reduce lung injury or improve clinical outcomes in patients hospitalized with COVID-19, ...
More blood pressure drugs are being recalled after being found to contain trace amounts of a potentially cancer-causing ingredient, one of a slew of recalls of medications to treat hypertension. Since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results